IDEXX Laboratories
Idexx Laboratories Quality Analysis
Idexx Laboratories (IDXX) is an exceptional quality business scoring 82/100. Key strengths include competitive moat, earnings predictability, financial strength. This is the type of durable, high-quality business that long-term investors should want to own at the right price.
Does IDEXX Laboratories have a strong competitive moat?
Idexx Laboratories shows a solid competitive position with solid gross margins of 60.2%. However, some vulnerability to competitive pressure suggests the moat, while present, may face challenges. The business earns above-average returns but lacks the exceptional durability of the strongest moats.
Does IDEXX Laboratories have pricing power in its industry?
Idexx Laboratories demonstrates moderate pricing power. The company maintains healthy margins and has been able to grow revenue without significant margin compression. Encouragingly, margins have been expanding. This suggests reasonable, though not exceptional, ability to pass costs through to customers.
How predictable is IDEXX Laboratories's business?
Idexx Laboratories is a highly predictable business with remarkably consistent financial performance. Revenue growth has been steady with low volatility, and the company has delivered positive free cash flow in 7 of the last 7 years. This consistency makes future earnings relatively easy to forecast with confidence.
Is IDEXX Laboratories financially strong?
Idexx Laboratories maintains a solid financial position. Debt levels are manageable, and the company generates sufficient cash to service its obligations. While not a fortress balance sheet, the financial position poses no immediate concerns and provides reasonable flexibility.
How effective is IDEXX Laboratories's capital allocation strategy?
Idexx Laboratories demonstrates excellent capital allocation, averaging 53.3% return on capital while reducing shares outstanding through buybacks. Management deploys capital at rates well above the cost of capital, creating significant value for shareholders.
The allocation between reinvestment, buybacks, and dividends appears disciplined and shareholder-friendly.
Does IDEXX Laboratories have high-quality management?
Idexx Laboratories's management team demonstrates strong execution, with stock-based compensation kept to just 1.4% of revenue. Consistent high returns on capital and stable operating margins indicate a team focused on operational excellence and long-term value creation rather than short-term metrics.
Is IDEXX Laboratories a quality company?
IDEXX Laboratories is a good quality company with a quality score of 82/100
Predicted probability of operating margin improvement over the next 12 months
- Management is the strongest dimension at 95/100.
- Average gross margin of 60.2% over 5 years.
- Positive free cash flow in 7 of the last 7 years.
- Debt-to-equity ratio of 0.24x.
What is the fair value of IDEXX Laboratories stock?
Is IDEXX Laboratories a good investment at $563?
The following analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. The opinions expressed are based on publicly available information and historical data. Beanvest and its contributors may hold positions in the securities mentioned. Investors should conduct their own due diligence or consult a licensed financial advisor before making any investment decision.